FDA Investigator: Diaz Albert, Jacqueline M

- Diaz Albert, Jacqueline M first started conducting FDA inspections in 2000, with the last inspection in 2022. Over that time, Diaz Albert, Jacqueline M has conducted 157 inspections at 113 companies across 120 sites.

Get Diaz Albert, Jacqueline M's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Spark Therapeutics, Inc., Philadelphia | 2022

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Jubilant HollisterStier LLC, Spokane | 2021

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC, Sanford | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Sagent Pharmaceuticals, Inc., Raleigh | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Haemtech Biopharma Services, Essex Junction | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Protein Sciences Corporation, Pearl River | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Sanofi Pasteur SA, Marcy L Etoile | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Avioq, Inc., Durham | 2019

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Octapharma Gmbh, Dessau-Roslau | 2018

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Takeda Austria GmbH, Linz | 2018

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

FDA 483 Kedrion Biopharma Inc., Melville | 2018

Out-of-stock
Diaz Albert, Jacqueline M
Biologic Form 483

Co-Investigators (52)